Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
Conditions
Interventions
Intervention1: Study Group (Unani Drug group): Qurs-e-Zarishk: Method of
Preparation- The drug will be
prepared in single batch on the guidelines and method of
preparation described in the
National Fo
Sponsors
National Research Institute of Unani Medicine For Skin Disorders
Eligibility
Inclusion criteria
Inclusion criteria: Newly diagnosed participants of any sex aged 30-60 years. Participants having any one or more of following lipid abnormality in blood: Serum Cholesterol equal to or more than 200mg/dl. HDL-C less than 40 mg/dl. LDL Cholesterol equal to or more than 130 mg/dl. Serum Triglycerides level equal to or more than 150mg/dl and/or less than 400 mg/dl. Body Mass Index (BMI) 23-40 kg/m2.
Exclusion criteria
Exclusion criteria: Participants having hypothyroidism, diabetes mellitus, history and clinical evidence of angina, myocardial infarction (MI). Pregnant or Lactating Women. Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction. Known cases of Immunocompromised states (HIV/ AIDS, etc)/ Malignancies. Participants not willing to attend treatment schedule regularly.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in serum triglyceride level from baseline to post treatment(8weeks).Timepoint: At baseline, 4th weeks and 8 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in total cholesterol (TC), low density lipoprotein (LDL), and increase in high density lipoprotein (HDL). Change in BMI, Weight, Waist, Hip, and Waist/Hip ratio from baseline to post treatment at 8weeks.Timepoint: At baseline, 4th weeks and 8th weeks. | — |
Countries
India
Contacts
Public ContactDr.Hafsa Patel
National Research Institute of Unani Medicine For Skin Disorders
Outcome results
None listed